Medicare Enrolled

Dr. Fariba Farhidvash, M.D., M.P.H.

Neurology · Temecula, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
44045 MARGARITA RD STE 106, Temecula, CA 92592
9514624624
In practice since 2006 (19 years)
NPI: 1831277946 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Farhidvash from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Farhidvash? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Farhidvash

Dr. Fariba Farhidvash is a neurology specialist in Temecula, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Farhidvash performed 653 Medicare services across 499 unique beneficiaries.

Between the years covered by Open Payments, Dr. Farhidvash received a total of $15,348 from 72 pharmaceutical and/or device companies across 603 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Farhidvash is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 41% volume in CA $15,348 industry payments

Medicare Practice Summary

Medicare Utilization ↗
653
Medicare services
Top 41% in CA for neurology
499
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~34 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Assessment of emotional or behavioral problems
An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns.
227 $4 $11
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
128 $67 $194
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
109 $115 $348
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
71 $92 $273
New patient office visit, complex (60-74 min) 39 $175 $468
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
31 $143 $379
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
26 $388 $1,015
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
22 $344 $876
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,348
Total received (2018-2024)
Avg $2,193/year across 7 years
Top 18% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
603
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,267 (79.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,051 (19.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$31 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,482
2023
$3,027
2022
$1,228
2021
$946
2020
$851
2019
$2,841
2018
$1,973

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$3,051
ABBVIE INC.
$915
MDD US Operations, LLC
$101
SK Life Science, Inc.
$73
Neurelis, Inc.
$64
Lundbeck LLC
$53
Lilly USA, LLC
$42
HARMONY BIOSCIENCES LLC
$35
Neurocrine Biosciences, Inc.
$31
JAZZ PHARMACEUTICALS INC.
$30
Aucta Pharmaceuticals, Inc.
$29
LivaNova USA, Inc.
$23
Teva Pharmaceuticals USA, Inc.
$19
Averitas Pharma Inc.
$18
Top 3 companies account for 90.7% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$4,068
ABBVIE INC.
$1,891
LivaNova USA, Inc.
$897
Teva Pharmaceuticals USA, Inc.
$849
Allergan Inc.
$561
SK Life Science, Inc.
$542
Amgen Inc.
$512
Biogen, Inc.
$444
Novartis Pharmaceuticals Corporation
$340
Lilly USA, LLC
$328
GENZYME CORPORATION
$317
AbbVie Inc.
$307
Supernus Pharmaceuticals, Inc.
$299
Alexion Pharmaceuticals, Inc.
$292
Greenwich Biosciences, Inc.
$262
Lundbeck LLC
$207
Avanir Pharmaceuticals, Inc.
$200
ACADIA Pharmaceuticals Inc
$186
EISAI INC.
$173
MDD US Operations, LLC
$146
Allergan, Inc.
$138
Eisai Inc.
$133
US WorldMeds, LLC
$119
Bausch Health US, LLC
$100
Upsher-Smith Laboratories LLC
$100
Neurelis, Inc.
$99
Neurocrine Biosciences, Inc.
$97
Adamas Pharmaceuticals, Inc.
$91
AbbVie, Inc.
$90
EMD Serono, Inc.
$90
CSL Behring
$82
Biohaven Pharmaceutical Holding Company Ltd.
$74
Jazz Pharmaceuticals Inc.
$72
Grifols USA, LLC
$65
PFIZER INC.
$57
Octapharma USA, Inc.
$54
Egalet US Inc
$54
Acorda Therapeutics, Inc
$52
Amneal Pharmaceuticals LLC
$50
Vertical Pharmaceuticals, LLC
$45
Sunovion Pharmaceuticals Inc.
$44
Genentech USA, Inc.
$44
Aprecia Pharmaceuticals, LLC
$43
Axsome Therapeutics, Inc.
$40
GE HEALTHCARE
$39
Promius Pharma LLC
$38
Zyla Life Sciences
$37
Endo Pharmaceuticals Inc.
$36
ASSERTIO THERAPEUTICS, Inc.
$35
HARMONY BIOSCIENCES LLC
$35
Akcea Therapeutics, Inc.
$34
Harmony Biosciences LLC
$32
JAZZ PHARMACEUTICALS INC.
$30
Nevro Corp.
$29
Aucta Pharmaceuticals, Inc.
$29
Horizon Therapeutics plc
$27
Cala Health, Inc.
$26
Mallinckrodt LLC
$24
TG THERAPEUTICS, INC.
$23
UPSHER-SMITH LABORATORIES LLC
$23
Biohaven Pharmaceuticals, Inc.
$22
Abbott Laboratories
$21
Sumitomo Pharma America, Inc.
$20
Mallinckrodt Hospital Products Inc.
$18
Averitas Pharma Inc.
$18
Shire North American Group Inc
$16
Cranial Technologies, Inc
$16
GE Healthcare
$16
Kyowa Kirin, Inc.
$15
Takeda Pharmaceuticals U.S.A., Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$12
AstraZeneca Pharmaceuticals LP
$12
Top 3 companies account for 44.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CALA KIQ · COMIRNATY · Cambia · DUOPA · Doc Band · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · FORTEO · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LUMIZYME · LYRICA · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NASCOBAL · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · None · Nuedexta · OCREVUS · ONFI · OSMOLEX ER · OXTELLAR XR · Omnia · PANZYGA · POMPE - DISEASE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RYTARY · Rebif · SOLIRIS · SPINRAZA · SPRIX · Soliris · Spritam · Sunosi · TECFIDERA · TEGSEDI · TOPIRAMATE Extended Release Capsules · TRINTELLIX · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trintellix · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VYEPTI · Vimpat · WAKIX · Wakix · XCOPRI · Xadago · ZEMBRACE SYMTOUCH · Zembrace · Zilbrysq · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Temecula?
Compare neurologists in the Temecula area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
16
Per 100K population
0.7
County median income
$89,672
Nearest hospital
TEMECULA VALLEY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Farhidvash is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Farhidvash experienced with assessment of emotional or behavioral problems?
Based on Medicare claims data, Dr. Farhidvash performed 227 assessment of emotional or behavioral problems services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Farhidvash receive payments from pharmaceutical companies?
Yes. Dr. Farhidvash received a total of $15,348 from 72 companies across 603 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Farhidvash's costs compare to other neurologists in Temecula?
Dr. Farhidvash's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Farhidvash) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →